Alejandro Rodríguez González

Dr. Alejandro Rodríguez González

Universidad Politécnica de Madrid
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Expert Systems with Applications
Verified
Journal Article
Closed access
AGAlejandro Rodríguez González
Alejandro Rodríguez González
Angel García-CrespoAngel García-Crespo
Angel García-Crespo
Ricardo Colomo-PalaciosRicardo Colomo-Palacios
Ricardo Colomo-Palacios
FIFernando Guldrís Iglesias
Fernando Guldrís Iglesias
JGJuan Miguel Gómez-Berbís
Juan Miguel Gómez-Berbís

3 September 2018 in Entropy
Verified
Journal Article
Open access
PDF file
Massimiliano ZaninMassimiliano Zanin
Massimiliano Zanin
AGAlejandro Rodríguez González
Alejandro Rodríguez González
Ernestina MenasalvasErnestina Menasalvas
Ernestina Menasalvas
DPDavid Papo
David Papo
Time irreversibility, i.e., the lack of invariance of the statistical properties of a system under time reversal, is a fundamental property of all systems operating out of equilibrium. Time reversal symmetry is associated with important statistical and physical properties and is related to the predictability of the system generating the time series. Over the past fifteen years, various methods to quantify time irreversibility in time series have been proposed, but these can be computationally expensive. Here, we propose a new method, based on permutation entropy, which is essentially parameter-free, temporally local, yields straightforward statistical tests, and has fast convergence properties. We apply this method to the study of financial time series, showing that stocks and indices present a rich irreversibility dynamics. We illustrate the comparative methodological advantages of our method with respect to a recently proposed method based on visibility graphs, and discuss the implications of our results for financial data analysis and interpretation.

16 August 2019 in Yearbook of Medical Informatics
Verified
Journal Article
Open access
PDF file
AGAlejandro Rodríguez González
Alejandro Rodríguez González
MZMassimiliano Zanin
Massimiliano Zanin
EMErnestina Menasalvas-Ruiz
Ernestina Menasalvas-Ruiz
Objectives: To provide an oveiview of the current application of artificial intelligence (AI) in the field of public health and epidemiology, with a special focus on antimicrobial resistance and the impact of climate change in disease epidemiology. Both topics are of vital importance and were included in the “Ten threats to global health in 2019“ report published by the World Health Organization. Methods: We analysed publications that appeared in the last two years, between January 2017 and October 2018. Papers were searched using Google Scholar with the following keywords: public health, epidemiology, machine learning, data analytics, artificial intelligence, disease surveillance, climate change, antimicrobial resistance, and combinations thereof. Selected articles were organised by theme. Results: In spite of a large interest in AI generated both within and outside the scientific community, and of the many opinions pointing towards the importance of a better use of data in public health, few papers have been published on the selected topics in the last two years. We identify several potential reasons, including the complexity of the integration of heterogeneous data, and the lack of sound and unbiased validation procedures. Conclusions: As there is a better comprehension of AI and more funding available, artificial intelligence will become not only the centre of attention in informatics, but more importantly the source of innovative solutions for public health.

1 June 2019 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
EVEduardo P. García del Valle
Eduardo P. García del Valle
GGGerardo Lagunes García
Gerardo Lagunes García
Lucía Prieto SantamaríaLucía Prieto Santamaría
Lucía Prieto Santamaría
MZMassimiliano Zanin
Massimiliano Zanin
ERErnestina Menasalvas Ruiz
Ernestina Menasalvas Ruiz
AGAlejandro Rodríguez González
Alejandro Rodríguez González

17 February 2020 in PeerJ
Verified
Journal Article
Open access
GLGerardo Lagunes-García
Gerardo Lagunes-García
AGAlejandro Rodríguez González
Alejandro Rodríguez González
Lucía Prieto SantamaríaLucía Prieto Santamaría
Lucía Prieto Santamaría
EVEduardo P. García del Valle
Eduardo P. García del Valle
MZMassimiliano Zanin
Massimiliano Zanin
EMErnestina Menasalvas-Ruiz
Ernestina Menasalvas-Ruiz
Background: Within the global endeavour of improving population health, one major challenge is the identification and integration of medical knowledge spread through several information sources. The creation of a comprehensive dataset of diseases and their clinical manifestations based on information from public sources is an interesting approach that allows one not only to complement and merge medical knowledge but also to increase it and thereby to interconnect existing data and analyse and relate diseases to each other. In this paper, we present DISNET (http://disnet.ctb.upm.es/), a web-based system designed to periodically extract the knowledge from signs and symptoms retrieved from medical databases, and to enable the creation of customisable disease networks. Methods: We here present the main features of the DISNET system. We describe how information on diseases and their phenotypic manifestations is extracted from Wikipedia and PubMed websites; specifically, texts from these sources are processed through a combination of text mining and natural language processing techniques. Results: We further present the validation of our system on Wikipedia and PubMed texts, obtaining the relevant accuracy. The final output includes the creation of a comprehensive symptoms-disease dataset, shared (free access) through the system’s API. We finally describe, with some simple use cases, how a user can interact with it and extract information that could be used for subsequent analyses. Discussion: DISNET allows retrieving knowledge about the signs, symptoms and diagnostic tests associated with a disease. It is not limited to a specific category (all the categories that the selected sources of information offer us) and clinical diagnosis terms. It further allows to track the evolution of those terms through time, being thus an opportunity to analyse and observe the progress of human knowledge on diseases. We further discussed the validation of the system, suggesting that it is good enough to be used to extract diseases and diagnostically-relevant terms. At the same time, the evaluation also revealed that improvements could be introduced to enhance the system’s reliability.

31 May 2023 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Open access
AGAlfredo Madrid García
Alfredo Madrid García
BMBeatriz Merino-Barbancho
Beatriz Merino-Barbancho
AGAlejandro Rodríguez González
Alejandro Rodríguez González
BFBenjamin Fernandez-Gutierrez
Benjamin Fernandez-Gutierrez
LRLuis Rodriguez-Rodriguez
Luis Rodriguez-Rodriguez
Ernestina MenasalvasErnestina Menasalvas
Ernestina Menasalvas
The major and upward trend in the number of published research related to rheumatic and musculoskeletal diseases, in which artificial intelligence plays a key role, has exhibited the interest of rheumatology researchers in using these techniques to answer their research questions. In this review, we analyse the original research articles that combine both worlds in a five- year period (2017-2021). In contrast to other published papers on the same topic, we first studied the review and recommendation articles that were published during that period, including up to October 2022, as well as the publication trends. Secondly, we review the published research articles and classify them into one of the following categories: disease identification and prediction, disease classification, patient stratification and disease subtype identification, disease progression and activity, treatment response, and predictors of outcomes. Thirdly, we provide a table with illustrative studies in which artificial intelligence techniques have played a central role in more than twenty rheumatic and musculoskeletal diseases. Finally, the findings of the research articles, in terms of disease and/or data science techniques employed, are highlighted in a discussion. Therefore, the present review aims to characterise how researchers are applying data science techniques in the rheumatology medical field. The most immediate conclusions that can be drawn from this work are: multiple and novel data science techniques have been used in a wide range of rheumatic and musculoskeletal diseases including rare diseases; the sample size and the data type used are heterogeneous, and new technical approaches are expected to arrive in the short-middle term.